Cargando…

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View

Parkinson’s disease (PD) is a degenerative neurological syndrome, which is characterized by the preferential death of dopaminergic (DAergic) neurons in the Substantia Nigra. The pathogenesis of this disorder remains poorly understood and PD is still incurable. Current drug treatments are aimed prima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filograna, Roberta, Beltramini, Mariano, Bubacco, Luigi, Bisaglia, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857623/ https://www.ncbi.nlm.nih.gov/pubmed/26517052 http://dx.doi.org/10.2174/1570159X13666151030102718

Ejemplares similares

Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity: IMPLICATIONS FOR PARKINSON DISEASE
por: Filograna, Roberta, et al.
Publicado: (2016)

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation
por: Filograna, Roberta, et al.
Publicado: (2015)

Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson’s Disease
por: Belluzzi, Elisa, et al.
Publicado: (2012)

Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss
por: Biosa, Alice, et al.
Publicado: (2018)

Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
por: Bisaglia, Marco, et al.
Publicado: (2020)

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
por: Agostini, Francesco, et al.
Publicado: (2021)

Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
por: Greggio, Elisa, et al.
Publicado: (2012)

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease
por: Agostini, Francesco, et al.
Publicado: (2023)

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)

Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018)

Oxidative Stress and Neuroinflammation in Parkinson’s Disease: The Role of Dopamine Oxidation Products
por: Chakrabarti, Sasanka, et al.
Publicado: (2023)

Mediterranean Diet and Parkinson’s Disease
por: Bisaglia, Marco
Publicado: (2022)

Antioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster
por: De Lazzari, Federica, et al.
Publicado: (2020)

Comprehensive Structural and Thermodynamic Analysis of Prefibrillar WT α-Synuclein and Its G51D, E46K, and A53T Mutants by a Combination of Small-Angle X-ray Scattering and Variational Bayesian Weighting
por: Moretti, Paolo, et al.
Publicado: (2020)

Erratum to: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
por: Russo, Isabella, et al.
Publicado: (2016)

Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
por: Russo, Isabella, et al.
Publicado: (2015)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
por: Bisaglia, Marco, et al.
Publicado: (2010)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Ceramides in Parkinson’s Disease: From Recent Evidence to New Hypotheses
por: Plotegher, Nicoletta, et al.
Publicado: (2019)

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View
por: Cenini, Giovanna, et al.
Publicado: (2019)

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
por: Bellucci, Arianna, et al.
Publicado: (2020)

Dopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
por: Rizzi, Giorgio, et al.
Publicado: (2017)

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Circadian Rhythm Abnormalities in Parkinson’s Disease from Humans to Flies and Back
por: De Lazzari, Federica, et al.
Publicado: (2018)

Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease
por: Masato, Anna, et al.
Publicado: (2021)

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
por: Masato, Anna, et al.
Publicado: (2023)

Calorimetry at LEP, a critical point of view
por: Videau, H L
Publicado: (1996)

DJ-1 and SOD1 Act Independently in the Protection against Anoxia in Drosophila melanogaster
por: De Lazzari, Federica, et al.
Publicado: (2022)

Anti-inflammatory and Anti-oxidant Activity of Hidrox(®) in Rotenone-Induced Parkinson’s Disease in Mice
por: Siracusa, Rosalba, et al.
Publicado: (2020)

View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson’s Disease: Are We on the Right Track?
por: Müller, Thomas
Publicado: (2021)

Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View
por: Bellati, Filippo, et al.
Publicado: (2011)

Anti-migraine agents from an immunological point of view
por: Assas, Mushref Bakri
Publicado: (2021)

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
por: Sulzer, David, et al.
Publicado: (2020)

Covalent α-Synuclein Dimers: Chemico-Physical and Aggregation Properties
por: Pivato, Micaela, et al.
Publicado: (2012)

Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment
por: Bacchella, Chiara, et al.
Publicado: (2023)

From the Nurses' Point of View: A Reply to the Criticisms of a Patient
Publicado: (1914)

Point of view
Publicado: (1998)

Points of view /
por: Maugham, W. Somerset

View Point
por: Tewari, Prabhat
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6bef75qd8lgmg3uqgrhgevj751